Methods: We performed a pre-specified analysis within the 3534 STEMI patients in TRITON-TIMI 38. Patients were randomized to prasugrel or clopidogrel on presentation if PPCI was intended or at the time of SecPCI. Since the clinical importance of procedural MI remains controversial, we performed sensitivity analyses excluding these events from the primary endpoint.